Global PE rush in ‘K-beauty’: How LYFE Capital’s Koru deal signals new paradigm of buy-and-build

Global PE rush in ‘K-beauty’: How LYFE Capital’s Koru deal signals new paradigm of buy-and-build

Photo from Koru Pharma

04 June, 2026

Edited by: Padma Priya

going global K-beauty Koru Pharma LBO Lyfe Capital medical aesthetics

Printed by Unregistered user on Thu, 04 Jun 2026 02:05:58 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Hahn & Co weighs secondary sale in medical aesthetics company

CBC-backed Dawn buys control of Vietnam medical device distributor Pinnacle

Read more from Greater China

China’s Dajin Heavy sets HK share sale at top end, raising up to $736.3m

DeepSeek set to raise $7b in first fundraising backed by CATL, Tencent, others